StonvexLoading…
StonvexStonvexStonvexCore line items from U's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $508.24M | $1.85B | $1.35B | $875.94M |
Operating Income | $-351.41M | $-479.05M | $-372.54M | $-246.69M |
Net Income | $-347.61M | $-402.76M | $-312.80M | $-186.44M |
EPS (Diluted) | $-0.80 | $-0.96 | $-0.75 | $-0.45 |
Total Assets | $6.52B | $6.84B | $6.78B | $6.72B |
Total Liabilities | $3.28B | $3.34B | $3.33B | $3.28B |
Cash & Equivalents | $2.14B | $2.06B | $1.90B | $1.69B |
Free Cash Flow OCF − CapEx | $66.46M | $403.93M | $285.25M | $133.96M |
Shares Outstanding | 436.40M | 432.86M | 427.78M | 420.44M |